Comments on: PCSK9 inhibitors: Specific studies are mandatory to prove efficacy and safety in CKD

Comments on: PCSK9 inhibitors: Specific studies are mandatory to prove efficacy and safety in CKD https://bioengineer.org/pcsk9-inhibitors-specific-studies-are-mandatory-to-prove-efficacy-and-safety-in-ckd/ Bioengineering Thu, 13 Jun 2019 15:24:37 +0000 hourly 1 https://wordpress.org/?v=7.0